Published in J Orthop Surg Res on January 28, 2015
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88
Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med (2003) 5.02
Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 3.78
Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg (2006) 2.52
EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. Lancet (1964) 2.34
Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA (1985) 2.00
Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br (1991) 1.69
General versus spinal/epidural anaesthesia for surgery for hip fractures in adults. Cochrane Database Syst Rev (2000) 1.50
Regional versus general anesthesia in high-risk surgical patients: the need for a clinical trial. J Clin Anesth (1989) 1.41
Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology (2003) 1.28
Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty (1997) 1.16
Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13
Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty (2003) 1.12
The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics (1994) 1.09
Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res (1987) 1.06
Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc (2000) 1.02
Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Br (2004) 1.02
A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest (2005) 0.98
Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res (2010) 0.88
Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics (1997) 0.84
Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement. J Bone Joint Surg Br (2011) 0.84
The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg (2006) 0.84
Complications of perioperative warfarin therapy in total knee arthroplasty. J Arthroplasty (2013) 0.81
Perioperative management of chronic anticoagulation in orthopaedic surgery. J Am Acad Orthop Surg (2010) 0.80
Cataract surgery and anticoagulants. J La State Med Soc (1996) 0.79
Perioperative anticoagulant management. Anesthesiol Clin (2009) 0.78
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust (2005) 0.78